Psoriasis

The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.

Latest News

Psoriasis skin, eczema, rash and other skin diseases. | Image credit: stockmaster - stock.adobe.com.jpg
Patients With GPP Face Elevated Mortality Risk, Study Finds

June 3rd 2025

US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared with the general population.

woman with psoriasis | Image credit: Andrey Popov - stock.adobe.com
Biosimilar Starjemza Gains FDA Approval as Ustekinumab Shows Significant Psoriasis-Itch Relief

May 29th 2025

Plaque psoriasis | Image credit: Milan Lipowski - stock.adobe.com
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis

May 22nd 2025

Woman with psoriasis | Andrey Popov - stock.adobe.com
Clinical Severity May Not Correlate With Psychological Burden of Psoriasis, Study Finds

May 7th 2025

Medicines on shelf - Prasanth - stock.adobe.com.jpg
Rising Costs of Biologics for Plaque Psoriasis Highlight Savings Potential

April 24th 2025

A Personalized Approach to Disease Management in Psoriasis

A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.

Ryan Haumschild, PharmD, MS, MBA, Bhavesh Shah, PharmD, Mark Lebwohl, MD, and Robert Groves, MD.
Continuing Medical Education
View All
June 6th 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
June 6th 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology

More News

Treating RA With Anti-TNF Agents Is Linked With a Higher Risk of Incident Psoriasis
August 19th 2019

Treating RA With Anti-TNF Agents Is Linked With a Higher Risk of Incident Psoriasis

Kelly Davio
Biologics have become the standard of care for rheumatoid arthritis (RA) that fails to respond adequately to conventional disease-modifying antirheumatic agents (DMARDs), and overall, these agents are safe and effective. However, an association between treatment with anti–tumor necrosis factor (anti-TNF) agents and new-onset psoriasis in patients with RA has been observed.
Researcher Excited About Future of Psoriasis Treatment
August 16th 2019

Researcher Excited About Future of Psoriasis Treatment

Allison Inserro
A psoriasis researcher discusses a new class of psoriasis treatments.
Obesity, Insulin Resistance Are Linked With Advanced Liver Fibrosis in Patients With Psoriasis
August 12th 2019

Obesity, Insulin Resistance Are Linked With Advanced Liver Fibrosis in Patients With Psoriasis

Kelly Davio
“Our data suggest that people with central obesity, insulin resistance, and active psoriasis are the most at risk for liver fibrosis,” wrote the authors, and “if use of methotrexate is a risk factor, it is not the only risk factor and for most patients it is unlikely to be the most important risk factor.”
Subclinical Atherosclerosis Seen in Patients With Psoriatic Arthritis
August 9th 2019

Subclinical Atherosclerosis Seen in Patients With Psoriatic Arthritis

AJMC Staff
A recent review of biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis (PsA) showed more severe atherosclerotic disease compared with patients who have only psoriasis.
Systematic Review Finds No Increased Risk to Fetus After Parental Exposure to Biologics for Psoriasis
August 5th 2019

Systematic Review Finds No Increased Risk to Fetus After Parental Exposure to Biologics for Psoriasis

During a recent meeting of the British Association of Dermatologists, a team of researchers from the United Kingdom reported on a systematic review of literature on adults exposed to biologics during conception and/or pregnancy, and they report that they did not find increased risk to the fetus following maternal or paternal biologic exposure.
Biologic Therapy for Psoriasis Reduced Coronary Inflammation, Study Says
July 31st 2019

Biologic Therapy for Psoriasis Reduced Coronary Inflammation, Study Says

Allison Inserro
Biologic treatment for moderate to severe psoriasis was linked with reduced coronary inflammation as determined by a new imaging biomarker, according to a study published in JAMA Cardiology.
Meta-Analysis Shows Patients With Psoriasis at Significantly Elevated Risk for Cancer
July 29th 2019

Meta-Analysis Shows Patients With Psoriasis at Significantly Elevated Risk for Cancer

Kelly Davio
In a study presented at the British Association of Dermatologists’ 99th Annual Meeting in Liverpool, United Kingdom, July 2-4, 2019, researchers from the University of Manchester and the Salford Royal National Health Service Foundation Trust reported on an effort to assess evidence on the risk of cancer in patients with psoriasis. They found that there are a number of site-specific cancers for which patients with psoriasis are at elevated risk.
Therapeutic Drug Monitoring Can Help With Clinical Decision Making in Psoriasis, Study Says
July 27th 2019

Therapeutic Drug Monitoring Can Help With Clinical Decision Making in Psoriasis, Study Says

AJMC Staff
Therapeutic drug monitoring that includes the measurement of trough concentrations and anti-drug antibodies, along with clinical response, is a tool for clinical decision making.
Biologic Treatment Is Associated With Better Bone Health in Patients With Psoriatic Arthritis
July 23rd 2019

Biologic Treatment Is Associated With Better Bone Health in Patients With Psoriatic Arthritis

Kelly Davio
Given that psoriatic arthritis is associated with increased fracture risk, neutralizing the key proinflammatory and bone-destructive mediators of the disease, wrote the authors, appears to be important to restoring bone health.
Obesity More Common in Those With Psoriasis Alone Compared With Those With Wider Disease
July 19th 2019

Obesity More Common in Those With Psoriasis Alone Compared With Those With Wider Disease

AJMC Staff
While obesity is frequently observed in patients with psoriatic disease, it is even more common in those who have only psoriasis alone, researchers said.
Treating Psoriasis With Biologics May Have Cardiac Benefits
July 15th 2019

Treating Psoriasis With Biologics May Have Cardiac Benefits

Kelly Davio
The use of biologics to treat psoriasis has increased over time, and a recent study has demonstrated that these drugs may have benefits that extend well beyond clearing patients’ skin. The study, published in Cardiovascular Research, found that biologic therapy for psoriasis was associated with a reduction in coronary artery disease.
Survey: Why Patients With Psoriasis Turn to Complementary and Alternative Medicines
July 13th 2019

Survey: Why Patients With Psoriasis Turn to Complementary and Alternative Medicines

Allison Inserro
Patients with psoriasis frequently use complementary and alternative medicines to treat their symptoms.
Psoriasis Risk Rises Along With BMI, Research Finds
July 9th 2019

Psoriasis Risk Rises Along With BMI, Research Finds

Kelly Davio
A recent study used Mendelian randomization, which uses genetic variants to randomly allocate individuals to groups based on genotype, to further investigate the causal relationship between body mass index (BMI) and psoriasis. It found that as BMI rises, so too does the risk for developing psoriasis.
Examining Treatment Patterns of Patients With Moderate-to-Severe Plaque Psoriasis
July 2nd 2019

Examining Treatment Patterns of Patients With Moderate-to-Severe Plaque Psoriasis

Allison Inserro
A recent study examined prescription claims databases to determine treatment patterns of patients with moderate-to-severe psoriasis who started therapy with 1 of 5 drugs by later status of whether they had psoriatic arthritis or not.
Study Examines Link Between Psoriasis, Migraine
May 4th 2019

Study Examines Link Between Psoriasis, Migraine

Allison Inserro
Psoriasis might increase the risk of migraine, according to a recently published study, which theorized that the link involves inflammatory processes.
Are TNF Inhibitors Safe in Pregnancy?
November 2nd 2018

Are TNF Inhibitors Safe in Pregnancy?

Surabhi Dangi-Garimella, PhD
A review published in the International Journal of Molecular Sciences highlights existing knowledge gaps in understanding the safety and impact of tumor necrosis factor (TNF) α inhibitors in pregnant women suffering from inflammatory conditions such as psoriasis and rhaumatoid arthritis.
Site Logo
December 26th 2017

Contemporary Management of Moderate to Severe Plaque Psoriasis

Jashin J. Wu, MD
Review Finds Several Biologics Effective in Treating Form of Palmoplantar Psoriasis
December 13th 2017

Review Finds Several Biologics Effective in Treating Form of Palmoplantar Psoriasis

Samantha DiGrande
A systematic review of biologics used in to treat palmoplantar psoriasis and palmoplantar pustulosis, 2 diseases that affect the palms and the soles of feet, found several available biologics are at least 80% effective in 1 form of the disease, but that there is less data on how well these drugs work on other forms of the disease.
Study Finds Potential Vaccines for Psoriasis, Allergies, and Alzheimer Disease
November 2nd 2017

Study Finds Potential Vaccines for Psoriasis, Allergies, and Alzheimer Disease

Alison Rodriguez
New vaccine demonstrated positive results in treating psoriasis and cat allergy models, and may have potential to protect against Alzheimer disease.
Site Logo
September 16th 2017

Patients With Psoriasis Face Greater Risk of Alcohol-Related Mortality

Alison Rodriguez
Individuals with psoriasis face a greater risk of dying because of an alcohol-related death compared with people in the general population, according to recent research.
Site Logo
September 14th 2017

Report Discusses Trends of Psoriasis and Progress of the Global Psoriasis Atlas

Alison Rodriguez
Psoriasis has a significant presence, affecting about 125 million people globally, but current estimates are fragmented because of a lack of a global standard. A new report suggested that global data will need a standardized approach of collection and analysis in order for more accurate estimates of psoriasis’ presence.
Site Logo
September 2nd 2017

Severe Psoriasis Linked to Increased Risk of Death

Laura Joszt, MA
Psoriasis severity has been linked to increased risk of death in a new study published in the Journal of Investigative Dermatology. Researchers found that the risk of death increased for patients who had more surface area covered by psoriasis.
Site Logo
July 17th 2017

Comorbidities Associated With Psoriasis Create Burden Among Patients

Alison Rodriguez
Psoriasis, an inflammatory skin disease, is often linked to many comorbidities that affect treatment decisions and the overall management of the disorder, according to new research.
Site Logo
July 1st 2017

Psoriasis Linked to High Cholesterol Levels, Study Finds

Site Logo
June 12th 2017

Above-Label Doses for Treating Psoriasis Can Lead to Higher Annual Treatment Costs

Alison Rodriguez
Patients with psoriasis often have lower success treatments with biologic agents in clinical practice than clinical trials, leading to higher doses and therefore higher annual treatment costs.
Site Logo
May 3rd 2017

An American Journal of Managed Care® Symposium: Examining Treatment Advancements in Psoriasis and Psoriatic Arthritis

Site Logo
October 18th 2016

Biosimilar Price Wars: Pfizer's Biosimilar to Remicade Will Be Cheaper

Surabhi Dangi-Garimella, PhD
Pfizer's biosimilar to Remicade is expected to be available in pharmacies by the end of November.
Site Logo
October 2nd 2016

Emerging Therapies and Future Considerations for Treating Moderate-to-Severe Atopic Dermatitis

The 4-part lecture, “Practical Application of Novel Targeted Strategies in Moderate-to-Severe Atopic Dermatitis” covered the pathogenesis of atopic dermatitis (AD), new insights into the pathophysiology in AD, considerations for change in the treatment of AD, and the latest developments in treatment.
Site Logo
July 6th 2016

Easing the Economic and Clinical Burden of Psoriasis and Psoriatic Arthritis: The Role of Managed Care

Site Logo
June 20th 2016

Psoriasis and Psoriatic Arthritis Treatment

Alan Menter, MD
Over the past several years, an increased understanding of the pathophysiology of psoriasis and psoriatic arthritis has led to the development of several new biologic therapies.
<1
...
101112131415>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo